{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:59:35Z","timestamp":1788872375580,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.trim.2014.12.001","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T12:51:18Z","timestamp":1418734278000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Renal cancer treatment with recipient lymphocyte infusion enhanced the antitumor effect of nonmyeloablative allogeneic stem cell transplantation"],"prefix":"10.1016","volume":"32","author":[{"given":"Ario","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Tatsugami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisakata","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yokomizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Shiota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoe","family":"Itsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijiro","family":"Kiyoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Dejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Imada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunobu","family":"Yoshikai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.trim.2014.12.001_bb0005","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJM200009143431101","article-title":"Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation","volume":"343","author":"Childs","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trim.2014.12.001_bb0010","article-title":"A reduction of recipient regulatory T cells by cyclophosphamide contributes to an anti-tumor effect of nonmyeloablative allogeneic stem cell transplantation in mice","author":"Takeuchi","year":"2011","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.trim.2014.12.001_bb0015","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","article-title":"Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients","volume":"76","author":"Kolb","year":"1990","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.trim.2014.12.001_bb0020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.trim.2014.12.001_bb0025","first-page":"61","article-title":"Principles of graft-vs.-leukemia reactivity","volume":"1","author":"Truitt","year":"1995","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.trim.2014.12.001_bb0030","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/79526","article-title":"Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia","volume":"6","author":"Molldrem","year":"2000","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.trim.2014.12.001_bb0035","first-page":"796","article-title":"Donor leukocyte infusion from immunized donors increases tumor vaccine efficacy after allogeneic bone marrow transplantation","volume":"62","author":"Teshima","year":"2002","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.trim.2014.12.001_bb0040","first-page":"206","article-title":"Hemopoietic activity in bone marrow chimeras prepared with total lymphoid irradiation (TLI)","volume":"10","author":"Slavin","year":"1982","journal-title":"Exp Hematol"},{"issue":"11","key":"10.1016\/j.trim.2014.12.001_bb0045","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V77.11.2515.2515","article-title":"Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation","volume":"77","author":"Truitt","year":"1991","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.trim.2014.12.001_bb0050","first-page":"196","article-title":"Enhancement of GVL effect with rhIL-2 following BMT in a murine model for acute myeloid leukemia in SJL\/J mice","volume":"23","author":"Vourka-Karussis","year":"1995","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.trim.2014.12.001_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1084\/jem.171.1.97","article-title":"Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens","volume":"171","author":"Eto","year":"1990","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.trim.2014.12.001_bb0060","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.4049\/jimmunol.169.5.2390","article-title":"Promotion of skin graft tolerance across MHC barriers by mobilization of dendritic cells in donor hemopoietic cell infusions","volume":"169","author":"Eto","year":"2002","journal-title":"J Immunol"},{"issue":"21","key":"10.1016\/j.trim.2014.12.001_bb0065","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1158\/0008-5472.CAN-05-0457","article-title":"Renal cancer treatment with low levels of mixed chimerism induced by nonmyeloablative regimen using cyclophosphamide in mice","volume":"65","author":"Harano","year":"2005","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.trim.2014.12.001_bb0070","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1158\/0008-5472.CAN-08-2517","article-title":"Donor CD4 T cells are critical in allogeneic stem cell transplantation against murine solid tumor","volume":"69","author":"Kamiryo","year":"2009","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.trim.2014.12.001_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI3132","article-title":"Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"102","author":"Hill","year":"1998","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.trim.2014.12.001_bb0080","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nm0602-575","article-title":"Acute graft-versus-host disease does not require alloantigen expression on host epithelium","volume":"8","author":"Teshima","year":"2002","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.trim.2014.12.001_bb0085","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.juro.2010.07.033","article-title":"Mechanism of synergistic antitumor effect of sorafenib and interferon-alpha on treatment of renal cell carcinoma","volume":"184","author":"Takeuchi","year":"2010","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/j.trim.2014.12.001_bb0090","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jama.1994.03510360033032","article-title":"Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2","volume":"271","author":"Rosenberg","year":"1994","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.trim.2014.12.001_bb0095","first-page":"940","article-title":"Renal cell carcinoma: antitumor effects of leukocyte interferon","volume":"43","author":"Quesada","year":"1983","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.trim.2014.12.001_bb0100","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1084\/jem.190.12.1793","article-title":"A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription","volume":"190","author":"Van Den Eynde","year":"1999","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.trim.2014.12.001_bb0105","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<799::AID-IJC1>3.0.CO;2-U","article-title":"Molecular expression of PSMA mRNA and protein in primary renal tumors","volume":"80","author":"Dumas","year":"1999","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.trim.2014.12.001_bb0110","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V66.3.664.664","article-title":"Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts","volume":"66","author":"Martin","year":"1985","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.trim.2014.12.001_bb0115","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","article-title":"Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts","volume":"300","author":"Weiden","year":"1979","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.trim.2014.12.001_bb0120","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1078-0432.CCR-06-1578","article-title":"Cyclophosphamide-using nonmyeloablative allogeneic cell therapy against renal cancer with a reduced risk of graft-versus-host disease","volume":"13","author":"Eto","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.trim.2014.12.001_bb0125","first-page":"767","article-title":"Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia","volume":"18","author":"Huss","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.trim.2014.12.001_bb0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00007890-200102150-00017","article-title":"T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation","volume":"71","author":"Mattsson","year":"2001","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.trim.2014.12.001_bb0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2141.2004.05328.x","article-title":"Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation","volume":"128","author":"Dey","year":"2005","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.trim.2014.12.001_bb0140","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4049\/jimmunol.175.2.665","volume":"175","author":"Rubio","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.trim.2014.12.001_bb0145","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2002-12-3949","article-title":"Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-gamma","volume":"102","author":"Rubio","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.trim.2014.12.001_bb0150","first-page":"323","article-title":"Role of interferon-gamma in GVHD and GVL","volume":"2","author":"Yang","year":"2005","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.trim.2014.12.001_bb0155","first-page":"65","article-title":"Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients","volume":"13","author":"Dickinson","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.trim.2014.12.001_bb0160","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.bmt.1702712","article-title":"Predicting the severity of intestinal graft-versus-host disease from leukotriene B4 levels after bone marrow transplantation","volume":"26","author":"Takatsuka","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.trim.2014.12.001_bb0165","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.bbmt.2009.07.015","article-title":"Dichotomous role of interferon-gamma in allogeneic bone marrow transplant","volume":"15","author":"Lu","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.trim.2014.12.001_bb0170","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1182\/blood.V99.11.4207","article-title":"Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells","volume":"99","author":"Yang","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.trim.2014.12.001_bb0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.189.2.219","article-title":"Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis","volume":"189","author":"Tarrant","year":"1999","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.trim.2014.12.001_bb0180","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1182\/blood-2003-10-3387","article-title":"Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets","volume":"104","author":"Stelljes","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.trim.2014.12.001_bb0185","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2009.05.001","article-title":"Plasticity of CD4+ T cell lineage differentiation","volume":"30","author":"Zhou","year":"2009","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.trim.2014.12.001_bb0190","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.trim.2014.12.001_bb0195","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/eji.200324181","article-title":"CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative","volume":"34","author":"Ghiringhelli","year":"2004","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.trim.2014.12.001_bb0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.ju.0000162039.38023.5f","article-title":"Update on chemotherapy for advanced bladder cancer","volume":"174","author":"Rosenberg","year":"2005","journal-title":"J Urol"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632741400327X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632741400327X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:58:42Z","timestamp":1760810322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096632741400327X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S096632741400327X"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2014.12.001","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal cancer treatment with recipient lymphocyte infusion enhanced the antitumor effect of nonmyeloablative allogeneic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2014.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}